Navigation Links
REMICADE® Receives FDA Approval as First Biologic Treatment for Pediatric Ulcerative Colitis
Date:9/23/2011

as six treatments each year as maintenance therapy.

Janssen Biotech, Inc. discovered and developed REMICADE® and markets the product in the United States.  The Janssen Pharmaceutical Companies market REMICADE® in Canada, Central and South America, the Middle East, Africa, and Asia Pacific. 

In Japan, Indonesia, and Taiwan, Janssen Biotech, Inc. licenses distribution rights to REMICADE® to Mitsubishi Tanabe Pharma Corporation.  In Europe, Russia and Turkey, Janssen Biotech, Inc. licenses distribution rights to REMICADE® to Schering-Plough (Ireland) Company, a subsidiary of Merck & Co, Inc. 

Important Safety Information  

Only a doctor can recommend a course of treatment after checking a patient's health condition. REMICADE® (infliximab) can cause serious side effects such as lowering your ability to fight infections.  There are reports of serious infections caused by viruses, fungi or bacteria that have spread throughout the body, including tuberculosis (TB) and histoplasmosis.  Some of these infections have been fatal.  Your doctor should monitor you closely for signs and symptoms of TB during treatment with REMICADE®.

Unusual cancers have been reported in children and teenage patients taking TNF-blocker medicines. A rare form of fatal lymphoma has occurred mostly in teenage or young adult males with Crohn's disease or ulcerative colitis who were taking REMICADE® and azathioprine or 6-mercaptopurine.  For children and adults taking TNF blockers, including REMICADE®, the chances of getting lymphoma or other cancers may increase.

Patients should discuss any concerns about their health and medical care with their doctor.

Patients should let their doctors know if they have or ever had any of the following:

  • Tuberculosis (TB) or have been near someone who has TB. Your doctor wil
    '/>"/>

SOURCE Janssen Biotech, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE® After Inadequate Response to Enbrel® or Humira® Demonstrate Marked Clinical Improvement
2. Centocor Ortho Biotech Inc. Submits Application to FDA Seeking REMICADE® Pediatric Ulcerative Colitis Indication
3. FDA Advisory Committee Recommends Approval of REMICADE® for Treatment of Pediatric Ulcerative Colitis
4. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
5. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
8. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
9. CryoCor Receives FDA Approval for Right Atrial Flutter
10. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
11. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... , June 3, 2015  Lightlake Therapeutics ... addiction treatments based on its expertise in opioid ... Lightlake,s partner for treating opioid overdose with intranasal ... New Drug Application (NDA) to the United States ... spray formulation of naloxone, a drug intended to ...
(Date:6/3/2015)... 3, 2015  Halozyme Therapeutics, Inc. (NASDAQ: ... license agreement with AbbVie (NYSE: ABBV ) to ... with Halozyme,s ENHANZE ™ platform. ... will receive an initial $23 million payment, followed ... each of up to nine collaboration targets. These ...
(Date:6/3/2015)... 2015  VA North Texas Health Care System ... vBloc, a technology-based, scientifically advanced weight loss therapy.  ... called the Maestro® Rechargeable System that intermittently blocks ... involving food intake and processing between the brain ... customizable to meet the needs of a patient,s ...
Breaking Medicine Technology:Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Commences Rolling NDA Submission To The FDA For Intranasal Naloxone 2Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Commences Rolling NDA Submission To The FDA For Intranasal Naloxone 3Halozyme Enters Into Global Collaboration and Licensing Agreement With AbbVie 2Halozyme Enters Into Global Collaboration and Licensing Agreement With AbbVie 3VA North Texas First VA in the Country to Perform vBloc Implant, a Cutting-Edge Weight Loss Therapy 2VA North Texas First VA in the Country to Perform vBloc Implant, a Cutting-Edge Weight Loss Therapy 3
(Date:6/3/2015)... June 03, 2015 Loma Linda University ... negotiations with San Gorgonio Memorial Hospital (SGMH). The SGMH ... Thursday, May 28. , “Loma Linda University Health has ... Kerry Heinrich, chief executive officer, Loma Linda University Medical ... expand our services to this community.” , Under ...
(Date:6/3/2015)... 2015 “ Harmony ” was featured on ... look at the latest and coolest applications on the market ... AppWatch and technology expert, conducted the app review and shared ... to improve some aspect of their life. , A common ... people with difficulties in their life. However, hypnotherapy is intended ...
(Date:6/3/2015)... 03, 2015 Vancouver personal injury lawyers ... firm will now handle personal injury claims resulting due ... the rise, more and more people turn towards mass ... cause needless suffering, serious injury and also deaths. ... a bus accident in BC you may have an ...
(Date:6/3/2015)... 03, 2015 VeoMed and Decker ... online and mobile access to premier Continuing Medical ... of Certification (MOC) activities. , ... courses to Decker’s extensive lists of physicians, residents, ... access to VeoMed’s premier online and live-streamed courses. ...
(Date:6/3/2015)... Texas (PRWEB) June 03, 2015 ... and Analytics solutions, today announced the launch of ... EXtensions (DSX) for SAP® BusinessObjects™ Design Studio. The ... additional visualization capabilities and advanced functionalities into their ... the DSX suite, Visual BI is adding key ...
Breaking Medicine News(10 mins):Health News:Loma Linda University Health and Adventist Health Enter into Exclusive Affiliation Negotiations with San Gorgonio Memorial Hospital 2Health News:An Application to Enjoy Hypnotherapy Sessions at Home was featured on NewsWatch Television 2Health News:Jiwa Law Corporation Now Handles Personal Injury Claims Involving Bus Accidents 2Health News:VeoMed and Decker Intellectual Properties, the Owner of Scientific American Medicine, Announce a Partnership to Expand Access to Premier Online CME Courses 2Health News:Visual BI Launches Second Release for its Design Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio 2Health News:Visual BI Launches Second Release for its Design Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio 3
... causing strokes in young people, though the condition's progress can ... ,The disorder known as Fabry disease is characterised by ... nodular skin lesions and progressive renal insufficiency. ,It ... the body to process oils, waxes and fatty acids, reports ...
... centres in Singapore and India plan to expand joint ... cancer centre said Tuesday//. ,The cooperation between Singapore's ... Centre builds on a screening programme credited with cutting ... the Indian state by 40 percent. ,The ...
... a scene of pandemonium with protesting students on the ... on the other, causing apparent commotion amongst patients. The ... behind these protests. ,Patients have expressed consolation at ... Chandra Majumdar said “Normally, I have to wait for ...
... anti-cancer effects of exercise results from an increase in ... cell growth and cause cell death. ,A ... protein that inhibits the action of another protein called ... cell growth, due to which the result appears. ...
... According to the doctors at Queen’s Medical Centre, Nottingham it ... halt their growth//. Thalidomide created so much commotion when it ... caused horrific birth defects in 12,000 babies. The babies were ... from the market and is now unlicensed in the UK. ...
... According to a research it was found that radiotherapy given ... against breast cancer//. The researchers from UK and US said ... the recurrence of cancer when compared to the conventional regime ... of the 10-year trial which was funded by the Cancer ...
Cached Medicine News:Health News:Rare Genetic Disorder Could Cause Strokes In Young People 2
Worn by many professional athletes, EpiTrain is our most popular elbow support....
EpiPoint is a dynamic elbow strap for tennis elbow and other overuse conditions....
... Mayo Clinic Elbow Brace, featuring an innovative ... stability and comfort while allowing for immobilization, ... the elbow. The sturdy metal uprights provide ... hold the brace in position, ensure patient ...
... AliMed® Turnbuckle Elbow Orthosis applies ... extension or flexion. Controls elbow contracture ... unbalanced muscle strength. Also good for ... turnbuckle is tightened to apply tension ...
Medicine Products: